Cancer Translational Research Horizons

Dr. Gino Fallone
Co-Founder and Chair (formerly CEO) at MagnetTx Oncology Solutions; Professor and Director of the Division of Medical Physics at the Department of Oncology, University of Alberta

Dr. Spyro Mousses
Co-Founder and Chief Executive Officer of Systems Oncology

Dr. Aaron Fenster
Professor at the Department of Biomedical Engineering and Oncology, University of Western Ontario

Dr. Karin Stephenson
Director of Nuclear Research and Education Support of Nuclear Operations & Facilities, McMaster University

Dr. Udunna Anazodo
Assistant Professor in at the Department of Neurology and Neurosurgery, McGill University

Ms. Erin Cook
Director of Quality, Transformation, Evaluation, Value, Ethics, and Virtual Care at CIUSSS West-Central

Mr. Barry D. Stein
President and Chief Executive Officer at Colorectal Cancer Canada

Dr. André Diamant
PhD. Founder & Chief Executive Officer of Gray Oncology Solutions

Dr. Ariane Gomes
Chief Scientific Officer and Chief Executive Officer Baselmmune

Dr. Jean-François Millau
Co-founder and Chief Executive Officer of TATUM Bioscience

Dr. Michel L. Tremblay
Distinguished James McGill Professor, Department of Biochemistry at McGill University

Dr. Sara Mahshid
Professor at the Department of Bioengineering, McGill University

Dr. Nathalie Johnson
Associate Professor at the Department of Oncology, McGill University

Dr. Alan Spatz
Full Professor at the Department of Pathology, McGill University

Dr. Elie Haddad
Full Professor, Department of Pediatrics, Department of Microbiology, Immunology and Infectiology, Faculty of Medicine at University of Montreal

Dr. April Rose
Assistant Professor at the Department of Oncology, McGill University

Dr. Michel Bouvier
Professor of Biochemistry and Molecular Medicine and principal investigator at IRIC, Université de Montréal






Location
Hybrid event:
Jewish General Hospital | Block Amphitheatre (B-106)
3755 Chemin de la Côte-Sainte-Catherine Montréal, QC Canada, H3T 1E2
Dates
Registration period:
August 1, 2024 - 12:00 AM EDT - November 21, 2024 - 4:59 PM EST
Submission period:
November 12, 2024 - 8:00 AM EST - November 12, 2024 - 11:59 PM EST
Contact us
If you have any questions, please contact MCTRC@ladydavis.ca